
Frankie L. Stinson
Examiner (ID: 8117)
| Most Active Art Unit | 1746 |
| Art Unit(s) | 1792, 1711, 2402, 1746, 2899, 3405, 1743 |
| Total Applications | 3621 |
| Issued Applications | 3013 |
| Pending Applications | 138 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16991682
[patent_doc_number] => 20210230102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => PROCESS FOR PRODUCING UNSATURATED NITRILE
[patent_app_type] => utility
[patent_app_number] => 17/051324
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17051324
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/051324 | Process for producing unsaturated nitrile | May 14, 2018 | Issued |
Array
(
[id] => 13413027
[patent_doc_number] => 20180258056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-13
[patent_title] => AMINO QUINAZOLINES AS KINASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/978377
[patent_app_country] => US
[patent_app_date] => 2018-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15978377
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/978377 | AMINO QUINAZOLINES AS KINASE INHIBITORS | May 13, 2018 | Abandoned |
Array
(
[id] => 17489222
[patent_doc_number] => 11278503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
[patent_app_type] => utility
[patent_app_number] => 16/612961
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14264
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16612961
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/612961 | Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions | May 8, 2018 | Issued |
Array
(
[id] => 15475821
[patent_doc_number] => 10553798
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-04
[patent_title] => Fused polycyclic heteroaromatic compound, organic thin film including compound and electronic device including organic thin film
[patent_app_type] => utility
[patent_app_number] => 15/975212
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6095
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15975212
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/975212 | Fused polycyclic heteroaromatic compound, organic thin film including compound and electronic device including organic thin film | May 8, 2018 | Issued |
Array
(
[id] => 13552705
[patent_doc_number] => 20180327900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => Volatile Dihydropyrazinly and Dihydropyrazine Metal Complexes
[patent_app_type] => utility
[patent_app_number] => 15/975199
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7079
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15975199
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/975199 | Volatile Dihydropyrazinly and Dihydropyrazine Metal Complexes | May 8, 2018 | Abandoned |
Array
(
[id] => 13440563
[patent_doc_number] => 20180271824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => N4-PHENYL-QUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
[patent_app_type] => utility
[patent_app_number] => 15/975323
[patent_app_country] => US
[patent_app_date] => 2018-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15975323
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/975323 | N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases | May 8, 2018 | Issued |
Array
(
[id] => 17586557
[patent_doc_number] => 11324799
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-10
[patent_title] => Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease
[patent_app_type] => utility
[patent_app_number] => 16/609963
[patent_app_country] => US
[patent_app_date] => 2018-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 6
[patent_no_of_words] => 7486
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609963
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609963 | Gap junction intercellular communication modulators and their use for the treatment of diabetic eye disease | May 3, 2018 | Issued |
Array
(
[id] => 14596777
[patent_doc_number] => 10351570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/970740
[patent_app_country] => US
[patent_app_date] => 2018-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90751
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15970740
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/970740 | Compounds and uses thereof | May 2, 2018 | Issued |
Array
(
[id] => 16984585
[patent_doc_number] => 11071735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Treatment of inflammatory conditions and autoimmune diseases with glucose uptake inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/608233
[patent_app_country] => US
[patent_app_date] => 2018-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 8
[patent_no_of_words] => 24777
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608233
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608233 | Treatment of inflammatory conditions and autoimmune diseases with glucose uptake inhibitors | Apr 26, 2018 | Issued |
Array
(
[id] => 17680005
[patent_doc_number] => 11364235
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic
[patent_app_type] => utility
[patent_app_number] => 16/607168
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 9
[patent_no_of_words] => 8036
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607168
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607168 | Method for treating cancer using a BCL-2 inhibitor in conjunction with an alpha-emitting radioimmunotherapeutic | Apr 25, 2018 | Issued |
Array
(
[id] => 16941019
[patent_doc_number] => 11053240
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-06
[patent_title] => 2-amino-quinoline derivatives
[patent_app_type] => utility
[patent_app_number] => 16/608581
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13909
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 466
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16608581
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/608581 | 2-amino-quinoline derivatives | Apr 25, 2018 | Issued |
Array
(
[id] => 15454335
[patent_doc_number] => 20200039992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-06
[patent_title] => POLYMORPHIC FORM OF COMPOUND, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/606144
[patent_app_country] => US
[patent_app_date] => 2018-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/606144 | Polymorphic form of compound, preparation method and use thereof | Apr 25, 2018 | Issued |
Array
(
[id] => 15800069
[patent_doc_number] => 20200123177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => PYRROLOPYRIMIDINE DERIVATIVES USEFUL AS INHIBITORS OF INFLUENZA VIRUS REPLICATION
[patent_app_type] => utility
[patent_app_number] => 16/603951
[patent_app_country] => US
[patent_app_date] => 2018-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45205
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603951
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603951 | Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication | Apr 23, 2018 | Issued |
Array
(
[id] => 13621989
[patent_doc_number] => 20180362546
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => PYRIMIDINONES AS PI3K INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 15/959942
[patent_app_country] => US
[patent_app_date] => 2018-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15959942
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/959942 | Pyrimidinones as PI3K inhibitors | Apr 22, 2018 | Issued |
Array
(
[id] => 13507581
[patent_doc_number] => 20180305333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES
[patent_app_type] => utility
[patent_app_number] => 15/956640
[patent_app_country] => US
[patent_app_date] => 2018-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956640
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/956640 | SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE, AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES | Apr 17, 2018 | Abandoned |
Array
(
[id] => 16519441
[patent_doc_number] => 10870650
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Process for the preparation of amorphous idelalisib
[patent_app_type] => utility
[patent_app_number] => 16/607914
[patent_app_country] => US
[patent_app_date] => 2018-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3175
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16607914
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/607914 | Process for the preparation of amorphous idelalisib | Apr 10, 2018 | Issued |
Array
(
[id] => 16852785
[patent_doc_number] => 20210153530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => FOOD PROTECTING COMPOSITION FOR MEAT, MEAT PRODUCTS AND DAIRY PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/045403
[patent_app_country] => US
[patent_app_date] => 2018-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045403
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045403 | FOOD PROTECTING COMPOSITION FOR MEAT, MEAT PRODUCTS AND DAIRY PRODUCTS | Apr 6, 2018 | Abandoned |
Array
(
[id] => 17251099
[patent_doc_number] => 11186571
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-30
[patent_title] => Quinazolinone derivatives useful for imaging
[patent_app_type] => utility
[patent_app_number] => 16/500867
[patent_app_country] => US
[patent_app_date] => 2018-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 67
[patent_no_of_words] => 15795
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16500867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/500867 | Quinazolinone derivatives useful for imaging | Apr 5, 2018 | Issued |
Array
(
[id] => 16726440
[patent_doc_number] => 20210093587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => Methods and Compositions for Modulating Beta-Amyloid/Alpha7-nAChR Interactions
[patent_app_type] => utility
[patent_app_number] => 16/498898
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498898
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/498898 | Methods and compositions for modulating b-amyloid/a7-nAChR interactions | Apr 4, 2018 | Issued |
Array
(
[id] => 15524569
[patent_doc_number] => 20200054590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => METHOD OF PREPARING A COMPOSITION COMPRISING FERULIC ACID
[patent_app_type] => utility
[patent_app_number] => 16/603301
[patent_app_country] => US
[patent_app_date] => 2018-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3450
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16603301
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/603301 | Method of preparing a composition comprising ferulic acid | Apr 2, 2018 | Issued |